Desmopressin therapy in children and adults: pharmacological considerations and clinical implications.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Desmopressin therapy in children and adults: pharmacological considerations and clinical implications.
- Published In:
- European journal of clinical pharmacology, 78(6), 907-917 (2022)
- Authors:
- Chin, Xinyi, Teo, Shao Wei, Lim, Soo Ting, Ng, Yong Hong, Han, How Chuan, Yap, Fabian
- Database ID:
- RPEP-06049
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06049APA
Chin, Xinyi; Teo, Shao Wei; Lim, Soo Ting; Ng, Yong Hong; Han, How Chuan; Yap, Fabian. (2022). Desmopressin therapy in children and adults: pharmacological considerations and clinical implications.. European journal of clinical pharmacology, 78(6), 907-917. https://doi.org/10.1007/s00228-022-03297-z
MLA
Chin, Xinyi, et al. "Desmopressin therapy in children and adults: pharmacological considerations and clinical implications.." European journal of clinical pharmacology, 2022. https://doi.org/10.1007/s00228-022-03297-z
RethinkPeptides
RethinkPeptides Research Database. "Desmopressin therapy in children and adults: pharmacological..." RPEP-06049. Retrieved from https://rethinkpeptides.com/research/chin-2022-desmopressin-therapy-in-children
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.